Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.25.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 2,774 $ 1,520 $ 207,769,904 $ (189,099,618) $ 253,734 $ (5,281,180) $ 13,647,134
Beginning balance, shares at Dec. 31, 2022 2,774,394 1,519,360          
Issuance of common stock to adjust for reverse split rounding $ 16 (16)
Issuance of common stock to adjust for reverse split rounding, shares   15,941          
Conversion of Series A preferred stock to shares of common stock $ (970) $ 8 962
Conversion of Series A preferred stock to shares of common stock, shares (970,000) 8,084          
Share-based expense 283,085 283,085
Net loss (4,134,578) (4,134,578)
Ending balance, value at Dec. 31, 2023 $ 1,804 $ 1,544 208,053,935 (193,234,196) 253,734 (5,281,180) 9,795,641
Ending balance, shares at Dec. 31, 2023 1,804,394 1,543,385          
Issuance of common stock in connection with restricted stock units
Issuance of common stock in connection with restricted stock units, shares   417          
Exercise of purchase warrants $ 1 (1)
Exercise of purchase warrants, shares   1,038          
Share-based expense 171,814 171,814
Net loss (3,960,275) (3,960,275)
Ending balance, value at Dec. 31, 2024 $ 1,804 $ 1,545 $ 208,225,748 $ (197,194,471) $ 253,734 $ (5,281,180) $ 6,007,180
Ending balance, shares at Dec. 31, 2024 1,804,394 1,544,840